This article discusses the formation processes and morphological features of the simultaneous presence of malignant tumors and pulmonary tuberculosis. The paper examines the mechanisms that contribute to the development of these diseases in their combined presence, as well as describes the characteristic morphological changes in tissues. The analysis provides a deeper understanding of the interaction between malignant neoplasms and pulmonary tuberculosis, which can contribute to the development of more effective methods of diagnosis and treatment.

malignant tumors, pulmonary tuberculosis, morphological features, mechanisms of development, concomitant diseases, diagnosis, treatment.

A. Sadovnikov, K. I. Panchenko. Infiltrative tuberculosis and lung cancer/ Problems of tuberculosis and lung diseases. - 1-2007. - p. 55-60.

V. Vencevicius, S. Tsitsenas, R. Tikuisis. Possibilities of surgical treatment in combination of tuberculosis and lung cancer. / Problems of tuberculosis and lung diseases- 5 - 2007 - P. 32-36.

S. Zinoviev, V. L. Kovalenko. Questions of morphology and pathogenesis of primary lung cancer in combination with pulmonary forms of tuberculosis. / Scientific works of the Omsk Medical Institute. - 1971g. - 103-P. 101-106. 4. A. A. Sadovnikov, K. I. Panchenko. The relationship between the tumor and tuberculosis process in the lung./ Thoracic and cardiovascular surgery-4-1995 p. 51-56.

Dacosta NA, Krinare SG. Association of lung carcinoma and tuberculosis // J Postgrad Med. – 1991. - №37(4). – Р.185-189.

Darvin P., Toor S.M., Sasidharan V. N., E. Elkord, Immune checkpoint inhibitors: recent progress and potential biomarkers, Exp. // Mol. Med. – 2018. - №50. – Р.165.

Delaunay M., Cadranel J., Lusque A., Meyer N., Gounant V., Moro-Sibilot D., et al. Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients // Eur. Respir. J. – 2017. - №50. – Р.1700050.

Dobler C. C. Cumulative incidence and incidence rate ratio for estimation of risk of tuberculosis in patients with cancer // Clin. Infect. Dis. – 2017. – Vol. 65, № 8. – P. 1423-1424.

Dobler C.C. Biologic agents and tuberculosis // Microbiol Spectr. – 2016. - №4.- Р.1128

Dobler C.C. Biological agents and tuberculosis: risk estimates and screening strategies // Int J Rheum Dis. – 2015. - №18. – Р.264–267.

Dobler C.C., Cheung K., Nguyen J. et al. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis // Eur Respir J. – 2017. - №50. – Р.1700157.